tirzepatide pregnancy news Weight-loss drug approved to treat sleep apnea in Canada Hi - has anyone gotten

The new Medicare GLP-1 Bridge gives eligible Part D beneficiaries access to certain GLP-1 weight-loss medications for $50 per month

In prediabetes, metformin has evidence for delaying progression to type 2 diabetes in selected higher-risk groups, such as younger adults with higher body weight or people with a history of gestational diabetes

Pharmacological treatments that differentially target the pathophysiological mechanisms governing both obesity and OSA have been tested with some success, either as monotherapy or as adjunct therapies to other therapeutic approaches

KnopFKVilsbollTLarsenSHojbergPVVolundAMadsbadSet al